ClinicalTrials.Veeva

Menu

Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas. (ICALYRA)

F

Fondazione Policlinico Universitario Campus Bio-Medico

Status

Completed

Conditions

Pancreas Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05959213
FPUCampusBioMedico

Details and patient eligibility

About

In our multicenter retrospective study, preoperative CA 19.9 levels predicts the presence of lymph node metastasis at final histology in patients underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma .

Full description

A retrospective analysis have been conducted on more than 2.000 patients underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma radiologically resectable at the preoperative staging. Preoperatory levels of CA 19.9 were measured in order to identify a relation with nodal involvement at the pathological staging.

Enrollment

2,034 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients undergone pancreatoduodenectomy
  • No preoperative radiological suspicion of lymph node metastases.

Exclusion criteria

  • Age < 18

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems